Tobam Decreases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Tobam lowered its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,564 shares of the biopharmaceutical company’s stock after selling 730 shares during the period. Tobam’s holdings in Regeneron Pharmaceuticals […]

Related Keywords

Canada ,Marion Mccourt ,Arthurf Ryan ,Sunbelt Securities Inc ,Barclays ,Sutton Wealth Advisors Inc ,Regeneron Pharmaceuticals Inc ,Quarter For Regeneron Pharmaceuticals ,Royal Bank ,News Ratings For Regeneron Pharmaceuticals Daily ,Regeneron Pharmaceuticals ,Bruceg Allen Investments ,Fortitude Family Office ,Regeneron Pharmaceuticals Stock Performance ,Cantor Fitzgerald ,Regeneron Pharmaceuticals Company Profile ,Nasdaq ,Annis Gardner Whiting Capital Advisors ,Securities Exchange Commission ,Free Report ,Gardner Whiting Capital Advisors ,Family Office ,Wealth Advisors ,Director Arthur ,Truist Financial ,Get Free Report ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,